INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 253 filers reported holding INARI MED INC in Q3 2023. The put-call ratio across all filers is 3.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,686,009 | +11.0% | 56,361 | -1.4% | 0.03% | +16.0% |
| Q2 2023 | $3,322,120 | -0.3% | 57,140 | +5.9% | 0.02% | 0.0% |
| Q1 2023 | $3,330,503 | -3.9% | 53,944 | -1.1% | 0.02% | -10.7% |
| Q4 2022 | $3,465,800 | -14.5% | 54,528 | -2.3% | 0.03% | -20.0% |
| Q3 2022 | $4,055,419 | +28.4% | 55,829 | +20.1% | 0.04% | +34.6% |
| Q2 2022 | $3,159,631 | +85.2% | 46,472 | +146.9% | 0.03% | +136.4% |
| Q1 2022 | $1,705,935 | +53.0% | 18,821 | +54.1% | 0.01% | +22.2% |
| Q4 2021 | $1,115,046 | +12.5% | 12,217 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $990,799 | -13.1% | 12,217 | 0.0% | 0.01% | -18.2% |
| Q2 2021 | $1,139,602 | -51.3% | 12,217 | -44.2% | 0.01% | -50.0% |
| Q1 2021 | $2,342,337 | +687.4% | 21,891 | +542.3% | 0.02% | +633.3% |
| Q4 2020 | $297,484 | +26.5% | 3,408 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $235,220 | – | 3,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |